| __timestamp | BioMarin Pharmaceutical Inc. | Insmed Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 129764000 | 33534999 |
| Thursday, January 1, 2015 | 152008000 | 1982000 |
| Friday, January 1, 2016 | 209620000 | 2438000 |
| Sunday, January 1, 2017 | 241786000 | 2901000 |
| Monday, January 1, 2018 | 315264000 | 2423000 |
| Tuesday, January 1, 2019 | 359466000 | 24212000 |
| Wednesday, January 1, 2020 | 524272000 | 39872000 |
| Friday, January 1, 2021 | 470515000 | 44152000 |
| Saturday, January 1, 2022 | 483669000 | 55126000 |
| Sunday, January 1, 2023 | 577065000 | 65573000 |
| Monday, January 1, 2024 | 580235000 |
Unveiling the hidden dimensions of data
In the competitive landscape of biotechnology, cost efficiency is a critical metric for success. Over the past decade, BioMarin Pharmaceutical Inc. has consistently outperformed Insmed Incorporated in terms of cost of revenue. From 2014 to 2023, BioMarin's cost of revenue increased by approximately 345%, peaking in 2023. In contrast, Insmed's cost of revenue grew by about 95% over the same period. This stark difference highlights BioMarin's expansive operational scale compared to Insmed's more conservative growth. Notably, BioMarin's cost of revenue in 2023 was nearly nine times that of Insmed, underscoring its dominant market position. As the biotech industry continues to evolve, these trends offer valuable insights into the strategic priorities and operational efficiencies of these two companies. Investors and industry analysts should keep a close eye on how these dynamics play out in the coming years.
Comparing Cost of Revenue Efficiency: Pfizer Inc. vs Insmed Incorporated
Gilead Sciences, Inc. vs Insmed Incorporated: Efficiency in Cost of Revenue Explored
Takeda Pharmaceutical Company Limited vs Insmed Incorporated: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Insmed Incorporated and Catalent, Inc.'s Expenses
Insmed Incorporated vs Sarepta Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Insmed Incorporated vs Jazz Pharmaceuticals plc
Cost of Revenue Comparison: Insmed Incorporated vs Xenon Pharmaceuticals Inc.
BioMarin Pharmaceutical Inc. vs Pharming Group N.V.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: BioMarin Pharmaceutical Inc. vs Grifols, S.A.
BioMarin Pharmaceutical Inc. vs Bausch Health Companies Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: BioMarin Pharmaceutical Inc. and Agios Pharmaceuticals, Inc.
Cost of Revenue: Key Insights for BioMarin Pharmaceutical Inc. and Xencor, Inc.